1847 related articles for article (PubMed ID: 8329197)
1. Prognostic value of nucleolar size and size pleomorphism in choroidal melanomas.
Sørensen FB; Gamel JW; Jensen OA; Ladekarl M; McCurdy J
APMIS; 1993 May; 101(5):358-68. PubMed ID: 8329197
[TBL] [Abstract][Full Text] [Related]
2. Histidine decarboxylase and intracellular histamine in melanoma cells and in a T cell line.
Falus A; László V; Radvány Z; Hegyesi H; Kiss B; Bencsáth M; Darvas Z
Inflamm Res; 1997 Mar; 46 Suppl 1():S51-2. PubMed ID: 9098761
[No Abstract] [Full Text] [Related]
3. Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2A.
Martinetti A; Seregni E; Belli F; Mazzocchi A; Agresti R; Cascinelli N; Greco M; Bombardieri E
Anticancer Res; 1998; 18(3B):2027-30. PubMed ID: 9677461
[TBL] [Abstract][Full Text] [Related]
4. Anticarcinogenic and antimetastatic activity of Iscador.
Kuttan G; Menon LG; Antony S; Kuttan R
Anticancer Drugs; 1997 Apr; 8 Suppl 1():S15-6. PubMed ID: 9179361
[TBL] [Abstract][Full Text] [Related]
5. [Surgically treated malignant melanoma. The long-term results].
Meierovici D; Ceauşu M; Păun F
Chirurgia (Bucur); 1995; 44(4):69-71. PubMed ID: 8646029
[TBL] [Abstract][Full Text] [Related]
6. [Combined A- and B-scan echography of the eye (author's transl)].
Bigar F; Bosshard CT
Klin Monbl Augenheilkd; 1977 Jan; 170(1):24-32. PubMed ID: 850352
[TBL] [Abstract][Full Text] [Related]
7. Beta-thujaplicin zinc chelate induces apoptosis in mouse high metastatic melanoma B16BL6 cells.
Miyamoto D; Endo N; Oku N; Arima Y; Suzuki T; Suzuki Y
Biol Pharm Bull; 1998 Dec; 21(12):1258-62. PubMed ID: 9881634
[TBL] [Abstract][Full Text] [Related]
8. Extension of useful reagent shelf life beyond manufacturers' recommendations. Cell Markers Committee of the College of American Pathologists.
Tubbs RR; Nagle R; Leslie K; Pettigrew NM; Said JW; Corwin DJ; Rickert RR; Roche PC
Arch Pathol Lab Med; 1998 Dec; 122(12):1051-2. PubMed ID: 9870851
[TBL] [Abstract][Full Text] [Related]
9. Cellular vaccines.
Bartholeyns J; Romet-Lemonne JL; Chokri M; Buyse M; Velu T; Bruyns C; Van de Winkel JJ; Heeney J; Koopman G; Malmsten M; De Groote D; Monsigny M; Midoux P; Alarcon B
Res Immunol; 1998; 149(7-8):647-9. PubMed ID: 9851517
[TBL] [Abstract][Full Text] [Related]
10. Melan A/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution.
Hofbauer GF; Kamarashev J; Geertsen R; Böni R; Dummer R
Melanoma Res; 1998 Aug; 8(4):337-43. PubMed ID: 9764809
[TBL] [Abstract][Full Text] [Related]
11. Cancer cell heparanase activity associated with invasion and metastasis.
Nicolson GL; Nakajima M; Wakabayashi H; Boyd DD; Diaz D; Irimura T
Adv Enzyme Regul; 1998; 38():19-32. PubMed ID: 9762344
[No Abstract] [Full Text] [Related]
12. Micronucleus analysis in peripheral blood lymphocytes from melanoma patients treated with dacarbazine.
Miele M; Bonassi S; Bonatti S; Martini E; Miglio L; Ottaggio L; Queirolo P; Sertoli M; Abbondandolo A
Anticancer Res; 1998; 18(3B):1967-71. PubMed ID: 9677451
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.
Mordoh J; Kairiyama C; Bover L; Solarolo E
Medicina (B Aires); 1997; 57(4):421-7. PubMed ID: 9674264
[TBL] [Abstract][Full Text] [Related]
14. Opposing effects of suramin and DL-alpha-difluoromethylornithine on polyamine metabolism contribute to a synergistic action on B16 melanoma cell growth in vitro.
Gritli-Linde A; Björkman U; Delle U; Hultborn R; Johansson BR; Nannmark U; Linde A
Anticancer Res; 1998; 18(2A):863-70. PubMed ID: 9615733
[TBL] [Abstract][Full Text] [Related]
15. Melanoma-cell toxicity of cystemustine combined with O6-benzyl-N2-acetylguanosine.
Buchdahl C; Rolhion C; Glasser AL; Debiton E; Mounetou E; Madelmont JC; Laval F
Melanoma Res; 1998 Apr; 8(2):123-30. PubMed ID: 9610864
[TBL] [Abstract][Full Text] [Related]
16. Regulation of tumor cell motility by 12(S)-HETE.
Silletti S; Timar J; Honn KV; Raz A
Adv Exp Med Biol; 1997; 400B():683-92. PubMed ID: 9547619
[No Abstract] [Full Text] [Related]
17. Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma.
Mooney MM; Kulas M; McKinley B; Michalek AM; Kraybill WG
Ann Surg Oncol; 1998; 5(1):54-63. PubMed ID: 9524709
[TBL] [Abstract][Full Text] [Related]
18. Comparative antitumor activities of halichondrins and vinblastine against human tumor xenografts.
Fodstad O; Breistøl K; Pettit GR; Shoemaker RH; Boyd MR
J Exp Ther Oncol; 1996 Mar; 1(2):119-25. PubMed ID: 9414395
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral heterogeneity for and epigenetic modulation of mdr-1 expression in murine melanoma.
Yoon SS; Fidler IJ; Beltran PJ; Bucana CD; Wang YF; Fan D
Melanoma Res; 1997 Aug; 7(4):275-87. PubMed ID: 9293477
[TBL] [Abstract][Full Text] [Related]
20. DNA for genetic vaccination and therapy.
Moelling K
Cytokines Cell Mol Ther; 1997 Jun; 3(2):127-35. PubMed ID: 9287251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
